相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes
Peter C. Austin et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2017)
Relative dose intensity and therapy efficacy in different breast cancer molecular subtypes: a retrospective study of early stage breast cancer patients treated with neoadjuvant chemotherapy
Jia-qi Yuan et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
A review of relative dose intensity and survival in patients with metastatic solid tumors
Laura J. Havrilesky et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices
Neelima Denduluri et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Correlations Between Molecular Subtypes and Pathologic Response Patterns of Breast Cancers After Neoadjuvant Chemotherapy
Hee Jin Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Molecular Markers for Breast Cancer Diagnosis, Prognosis and Targeted Therapy
Julie E. Lang et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
A retrospective evaluation of chemotherapy dose intensity and supportive care for early-stage breast cancer in a curative setting
Gary H. Lyman et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Estrogen receptor status confers a distinct pattern of response to neoadjuvant chemotherapy: implications for optimal durations of therapy Distinct patterns of response according to ER expression
Hyeong-Gon Moon et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice
Derek Weycker et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting
Lisa M. McShane et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis
Sibylle Loibl et al.
BMC CANCER (2011)
Weight Trimming and Propensity Score Weighting
Brian K. Lee et al.
PLOS ONE (2011)
Use of Stabilized Inverse Propensity Scores as Weights to Directly Estimate Relative Risk and Its Confidence Intervals
Stanley Xu et al.
VALUE IN HEALTH (2010)
Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients
Isabel Chirivella et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Impact of Chemotherapy Dose Intensity on Cancer Patient Outcomes
Gary H. Lyman
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival
Adedayo Onitilo et al.
CLINICAL MEDICINE & RESEARCH (2009)
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study
Peter C. Austin et al.
STATISTICS IN MEDICINE (2007)
Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy
Michelle Shayne et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index
M Colleoni et al.
LANCET (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: A nationwide study of community practices
GH Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
